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ABSTRACT Neisseria meningitidis and Neisseria gonorrhoeae are pathogenic bacteria
that can cause human infections. While N. meningitidis infections are associated with
bacterial meningitis and bacteremia, a strain of N. meningitidis, isolated from the uro-
genital system, has recently been associated with urethritis. As this strain is becoming
prominent as an emerging pathogen, it is essential to assess identification tools for N.
meningitidis and N. gonorrhoeae urogenital isolates. Consecutive N. meningitidis isolates
recovered from urogenital cultures of symptomatic patients with presumptive diagno-
ses of gonorrhea and a random selection of N. gonorrhoeae isolates recovered from
the same population within the same time frame were characterized with routine
identification systems, antimicrobial susceptibility testing, and whole-genome sequenc-
ing. Matrix-assisted laser desorption ionization–time of flight mass spectrometry
(MALDI-TOF MS), multilocus sequence typing, 16S rRNA gene sequence, and average
nucleotide identity methods accurately identified 95% (18/19) of N. meningitidis and N.
gonorrhoeae isolates. With the Aptima Combo 2 CT/NG test, 30% (3/10) of N. meningiti-
dis isolates were misidentified as N. gonorrhoeae, but no misidentifications were found
with the Xpert CT/NG nucleic acid amplification test (NAAT). Phylogenetic core genome
and single nucleotide polymorphism (SNP)-based grouping analyses showed that uro-
genital N. meningitidis isolates were highly related and phylogenetically distinct from N.
gonorrhoeae and respiratory N. meningitidis isolates but similar to urogenital N. meningi-
tidis isolates from patients with urethritis in the United States. Urogenital N. meningitidis
isolates were predominantly azithromycin resistant, while N. gonorrhoeae isolates
were azithromycin susceptible. These data indicate that urogenital isolates of N. menin-
gitidis can cause false-positive detections with N. gonorrhoeae diagnostic assays.
Misidentification of urogenital N. meningitidis isolates may confound public health-
related activities for gonorrhea, and future studies are needed to understand the
impact on clinical outcome of N. meningitidis urogenital infection.
KEYWORDS Neisseria, urethritis, whole-genome sequencing, antibiotic resistance
N eisseria gonorrhoeae and Neisseria meningitidis are human bacterial pathogensthat can occupy different niches in the body (1, 2). N. gonorrhoeae is the causative
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agent of the sexually transmitted infection gonorrhea, which impacts 78 million people
worldwide (3). As an obligate pathogen, N. gonorrhoeae primarily colonizes the genital
mucosa and has evolved virulence factors that allow it to survive and evade the host
immune system (1). Recently, N. gonorrhoeae has received increased public health
attention, and drug-resistant N. gonorrhoeae has been categorized as an urgent threat
by the U.S. Centers for Disease Control and Prevention due to resistance to commonly
used antibiotics, limiting treatment in patients (4–6). Molecular point-of-care and sam-
ple-to-answer assays have been developed to rapidly and accurately identify the pres-
ence of N. gonorrhoeae in clinical specimens (7). While the development of these assays
is important for patient treatment, there is evidence for sporadic false-positive molecu-
lar results due to cross-reactivity between Neisseria species (8).
N. meningitidis is found as a commensal in the respiratory system, and ;10% of
healthy adults and 40% of men who have sex with men (MSM) demonstrate naso/oro-
pharyngeal carriage (2). N. meningitidis is also a leading cause of bacterial meningitis
and causes significant morbidity and mortality in children and young adults, with an
estimated 1.2 million cases of meningococcal infection per year worldwide (9). The vir-
ulence of N. meningitidis is determined by host factors (i.e., complement deficiency)
and several virulence genes that facilitate adherence and survival in the respiratory sys-
tem and invasion of the bloodstream (9).
The genus Neisseria has evolved mechanisms that result in a high frequency of hori-
zontal gene transfer (HGT), both within and between species, with up to 10% of the N.
meningitidis genome made up of mobile genetic elements (9, 10). Colocalization of N.
meningitidis and N. gonorrhoeae in the urogenital system may result in increased trans-
fer of virulence or antibiotic resistance genes (11). Recent studies have identified a
strain of N. meningitidis that has been isolated from the urogenital system and is asso-
ciated with urethritis (12–16). As this strain becomes a more prominent emerging
pathogen in areas with high N. gonorrhoeae infection rates, it is essential to assess the
ability of identification tools to discriminate between N. meningitidis and N. gonor-
rhoeae urogential isolates (13, 14, 17).
Following the implementation of a total laboratory automation system for culture-
based microbiology (BD Kiestra total laboratory automation (TLA) system; Beckton
Dickinson), the clinical microbiology laboratory at Barnes Jewish Hospital in St. Louis,
MO, observed significant increases in the recovery of N. gonorrhoeae and, more
recently, N. meningitidis incidentally from urine specimens submitted for routine cul-
ture-based testing (18). In this study, we characterize consecutively recovered N. men-
ingitidis and compare them to N. meningitidis urethritis and invasive strains reported
elsewhere.
MATERIALS ANDMETHODS
Clinical isolates and human study approval. Consecutive Neisseria meningitidis and a random
selection of Neisseria gonorrhoeae isolates recovered from March 2018 to March 2019 from clinical speci-
mens submitted for routine testing to the Barnes Jewish Hospital Clinical Microbiology Laboratory in St.
Louis, MO, were included in this study. Previous studies from our laboratory found increased recovery of
N. gonorrhoeae and N. meningitidis isolates incidentally from urine cultures submitted for routine testing
when incubated with the Kiestra total laboratory automation (TLA) (18). Study isolates were deidentified,
but patient age, gender, and isolate source were documented. This study was approved by the Human
Research Protection Office of Washington University School of Medicine.
Laboratory characterization. Frozen N. meningitidis and N. gonorrhoeae isolates were subcultured
to chocolate (CHC) agar (Hardy Diagnostics, Santa Maria, CA), incubated at 35°C and 5% CO2, and pas-
saged twice prior to additional testing. For phenotypic characterization, 10 ml of a 0.5 McFarland (McF)
suspension of each isolate was cross-struck to CHC and modified Thayer-Martin (MTM) (Hardy
Diagnostics, Santa Maria, CA) to achieve less subjective interpretation and was quadrant struck to a third
CHC plate with 10mg colistin disk (BD BBL, Sparks, MD). Following incubation at 35°C and 5% CO2 for 18
to 20 h, CFU were enumerated and the colistin zone size to the nearest millimeter was recorded. For bio-
chemical characterization, the RapidID NH system (Remel, Lenexa, KS) was used per the manufacturer’s
instructions. Briefly, biochemical strips were inoculated with 3 McF suspensions of each isolate and incu-
bated at 35°C for 4 h in air. Following incubation, biochemical reactions were read and scored, and
microcodes were interpreted using the ERIC system to obtain organism identifications. For molecular
characterization with matrix-assisted-laser desorption ionization–time of flight mass spectrometry
(MALDI-TOF MS), 2 commercially available systems were utilized, Bruker BioTyper (Bruker, Billerica, MA)
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and Vitek MS (bioMérieux, Durham, NC). Briefly, single colonies of pure growth were spotted to target
slides and overlaid with matrix prior to analysis on each instrument per the manufacturer’s instructions.
For N. meningitidis isolates, target slides were spotted with organism and matrix and fully dried inside a
biosafety cabinet (BSC) before removal for loading onto the MALDI-TOF MS instrument. For analysis with
commercial in vitro diagnostic (IVD) nucleic acid amplification tests (NAATs), both contrived swab and
urine specimens of N. meningitidis and N. gonorrhoeae isolates were tested to confirm the lack of matrix-
specific effects. Swabs from Aptima vaginal and Xpert vaginal/endocervical specimen collection kits
were inserted into a 0.5-McF suspension of each isolate for 10 s, or 0.5-McF isolate suspensions were
diluted 10-fold with remnant urine specimens previously determined to be negative for Chlamydia tra-
chomatis and Neisseria gonorrhoeae. Both contrived swab and urine specimens were tested with the
Aptima Combo 2 CT/NG (A-CT/NG) on the Tigris GTS system (Hologic, Inc., San Diego, CA) and the Xpert
CT/NG (X-CT/NG) assay on the GeneXpert Infinity system (Cepheid, Sunnyvale, CA) per the manufac-
turer’s instructions.
Antimicrobial susceptibility testing. Antimicrobial susceptibility testing (AST) of N. meningitidis
and N. gonorrhoeae isolates was performed using disk diffusion and gradient diffusion strips, and the
MIC and/or disk diffusion zone size was interpreted according to the Clinical and Laboratory Standards
Institute (CLSI) M100, 29th edition (19). For N. meningitidis isolates, 0.5 McF suspensions of test isolates
were inoculated to Mueller-Hinton Agar with 5% sheep blood and incubated with penicillin, azithromy-
cin, ceftriaxone ETESTs (bioMérieux, Durham, NC) and ciprofloxacin (5mg), rifampin (5mg), minocycline
(30mg) and trimethoprim-sulfamethoxazole disks (1.25/23.75mg) (BD BBLTM, Sparks, MD) at 35°C and 5%
CO2, for 20–24 h. For N. gonorrhoeae isolates, 0.5-McF suspensions of test isolates were inoculated to GC
agar base with 1% defined growth supplement and incubated with penicillin, azithromycin, ceftriaxone
Etests (bioMérieux, Durham, NC), and ciprofloxacin (5mg) and rifampin (5mg) disks (BD BBL, Sparks, MD)
at 35°C and 5% CO2, for 20 to 24 h. MIC doubling dilutions and zone sizes to the nearest millimeter were
read with reflected light and interpreted per CLSI M100, 29th edition, guidelines (19). AST categorical
results were visualized using pheatmap (R) with color strips used to indicate the source of the isolate,
species, and SNP pairwise distance-based grouping.
Whole-genome sequencing. Total genomic DNA was extracted from cell cultures suspended in
1ml of deionized water using the QIAamp BiOstic bacteremia DNA kit (Qiagen, Germantown, MD, USA).
We quantified the DNA concentration using Qubit double-stranded DNA (dsDNA) assays (Thermo Fisher
Scientific). Illumina sequencing libraries were prepared using 5 ng/ml of isolate DNA in a modified
Nextera kit protocol (Illumina, San Diego, CA, USA). We then pooled and sequenced libraries on a
NextSeq high-output platform (Illumina) to obtain ;2 million 2 150-bp reads. The reads were demulti-
plexed by barcode, adapters were removed with Trimmomatic v.36, and contaminating human sequen-
ces were removed with Deconseq v.4.3 (20, 21). We assembled processed reads into draft genomes
using the de novo assembler SPAdes v3.11 (22). The quality of draft genomes was assessed using QUAST
v.4.5 and CheckM (23, 24). Assembles were considered to have passed quality control when the assem-
bly length represented in contigs of ,1 kb was less than 10%, the number of contigs greater than
500bp was less than 5,000, completeness was greater than 90%, and contaminated reads were less than
5%. Draft genomes were annotated using Prokka v.1.12 (25).
Genomic taxonomic identification. Following draft genome assembly, we determined genomic
taxonomic identification by average nucleotide identity (ANI), 16S rRNA gene identification, and multilo-
cus sequence typing (MLST). The assembled scaffolds were submitted to the Neisseria multilocus
sequence typing website (https://pubmlst.org/neisseria/) to determine MLST and clonal complex (26).
For all isolates, 16S rRNA gene sequences were identified using RNAmmer v.1.2 and submitted to the EZ
BIoCloud taxonomic database for classification (27, 28). Using ANI analysis, species were determined if
the genome in question had .95% ANI with the type genome (N. meningitidis, NM_MC58; N. gonor-
rhoeae, NG_ref_FA_1090) using dnadiff (29). Pairwise ANI for each isolate was clustered and visualized
using pheatmap (R) (30).
Phylogenetic analysis. To phylogenetically compare isolate sequences, 16S rRNA gene sequences
identified by RNAammer were aligned using MUSCLE, and an approximate maximum likelihood tree
was built with FastTree (31, 32). FastTree uses a heuristic variant of neighbor joining to construct a rough
topology, reduces the length of the tree using a mix of nearest-neighbor interchanges and subtree-
prune-regraft moves, and improves the tree with maximum-likelihood rearrangements (32). Branch
length precision was rounded to 0.0001 substitutions per site. The output Newick files were visualized
and annotated with isolate source using ggtree (R) (33, 34). To compare isolate genomes, .gff files pro-
duced by Prokka were used to construct a core genome alignment with Roary v.3.8.0 for N. meningitidis
(35). Roary alignments were used to create an approximate maximum likelihood tree with FastTree (32).
The output Newick files were visualized and annotated with isolate source using ggtree (R) (33, 34).
Isolate groupings based on SNP pairwise distances. Snippy v.4.3.8 was used to map forward and
reserve reads for N. meningitidis isolates to the N. meningitidis MC58 type strain complete genome as-
sembly (ID) and to call SNPs (36). To determine groupings, we compared pairwise SNP distances
between each N. meningitidis isolate pair. Isolates were grouped into perfectly reciprocal groups at every
pairwise distance cutoff between N. meningitidis isolates using igraph v.1.2.4.1 as described previously
(37). Groupings were visualized with a SNP cutoff of 2,000.
Antibiotic resistance mutation identification and analysis. Targeted analysis of acquired antibi-
otic resistance genes/mutations (ARGs) against b-lactams (blaTEM, penA, porA, ponA, mtrR), macrolides/
lincosamides/streptogramins (23S rRNA, mtrR), and quinolones (gyrA, parC) was performed as a result of
phenotypic AST findings using PointFinder (38). The presence/absence matrix of ARGs was visualized in
pheatmap (R). Associated metadata were displayed as a color strip to represent bacterial isolate
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identification and Aptima CT results. We further validated PointFinder results for key resistance gene
mutations using BLASTn with MUSCLE alignment and maximum likelihood tree visualization (see Fig. S3
in the supplemental material).
Data availability. All assemblies are uploaded to the NCBI under BioProject PRJNA643774.
RESULTS
N. meningitidis urinary isolates can cause false-positive N. gonorrhoeae
molecular test result. Consecutive N. meningitidis isolates and a random selection of
N. gonorrhoeae isolates recovered from clinical specimens during the same time period
were characterized by phenotypic and molecular methods routinely used to identify
Neisseria species in clinical microbiology laboratories, including MALDI-TOF MS and
commercial biochemical and molecular tests. Detailed demographic information was
not available for these isolates, but limited information including patient age and gen-
der, and isolate source is summarized in Table 1. All urogenital N. meningitidis and N.
gonorrhoeae isolates were correctly identified using the Bruker Biotyper and Vitek MS
MALDI-TOF MS platforms (Table 1). One Neisseria isolate from a respiratory source
(NM12) was incorrectly identified using MALDI-TOF MS and biochemical tests as N.
meningitidis (Bruker Biotyper) or Neisseria polysaccharea/N. meningitidis (Vitek MS) and
N. gonorrhoeae (RapidID NH). However, this isolate was phenotypically consistent with
nonpathogenic Neisseria species with no growth on MTM medium and a zone of inhi-
bition when incubated with a 10-mg colistin disk on solid medium and was identified
using whole-genome sequencing (WGS) methods as N. polysaccharea.
Organism suspensions of each isolate were also tested with the Aptima CT/NG
Combo 2 assay (A-CT/NG) on the Tigris DTS system and Xpert CT/NG (X-CT/NG) on the
GeneXpert system. All N. gonorrhoeae isolates were detected by both systems, while all
N. meningitidis isolates were not detected by X-CT/NG. Importantly, urinary isolates of
N. meningitidis (NM04, NM07, NM08) tested positive for N. gonorrhoeae with A-CT/NG.























NM02 43, M Urine Nongroupable R, 6 Nm Nm Nm Neg Neg Nm ST-11
NM03 31, M Urine ND R, 6 Nm Nm Nm Neg Neg Nm No type
NM04 27, M Urine Nongroupable R, 6 Nm Nm Nm Ng Posc Negc Nm ST-11
NM05 18, F Urine ND R, 6 Nm Nm Nm Neg Neg Nm ST-11
NM06 31, M Urine W135 R, 6 Nm Nm Nm Neg Neg Nm ST-11
NM07 43, M Urine Nongroupable R, 6 Nm Nm Nm Ng Posc Negc Nm ST-11
NM08 23, M Urine Nongroupable R, 6 Nm Nm Nm Ng Posc Negc Nm ST-11
NM09 22, M Urine Nongroupable R, 6 Mo Nm Nm Negc Negc Nm ST-32
NM10 29, M Urine ND R, 6 Nm Nm Nm Neg Neg Nm ST-11
NM11 46, M Respiratory, Sp Nongroupable R, 6 Nm Nm Nm Neg Neg Nm No type
NM12 8, F Respiratory, TA NA S, 20 Ng Nm/Np Nm Negc Negc Np No type
NM13 21, F Respiratory, BAL Nongroupable R, 6 Nm Nm Nm Neg Neg Nm ST-11
NM14 71, M Respiratory, BW B R, 6 Mo Nm Nm Negc Negc Nm ST-11
NM15 32, M Genital Nongroupable R, 6 Nm Nm Nm Neg Neg Nm ST-4821
NG ATCC
49226
NA ND R, 6 Ng Ng Ng Ng Pos Ng Pos Ng No type
NG01 35, M Urine ND R, 6 Ng Ng Ng Ng Pos Ng Pos Ng No type
NG02 34, M Urine ND R, 6 Ng Ng Ng Ng Pos Ng Pos Ng No type
NG03 31, M Urine ND R 6 Ng Ng Ng Ng Pos Ng Pos Ng No type
NG04 29, M Urine ND R, 6 Ng Ng Ng Ng Pos Ng Pos Ng No type
NG05 23, M Urine ND R, 6 Ng Ng Ng Ng Pos Ng Pos Ng No type
aAbbreviations: M, male; F, female; Sp, sputum; TA, tracheal aspirate; BAL, bronchoalveolar lavage; BW, bronchial wash; Nm, Neisseria meningitis; Ng, Neisseria gonorrhoeae;
Np, Neisseria polysaccharea; Mo,Moraxella osloensis; ND, not done; NA, not applicable; R, resistant; S, susceptible; Pos, positive; Neg, negative for all targets.
bSerogroup determination or confirmatory testing performed by Missouri State Public health Laboratory (MSPHL) Jefferson City, MO.
cConfirmed by repeat testing in remnant urine matrix.
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This result was confirmed with remnant urine specimens spiked with NM04, NM07,
NM08, NM09, NM12, and NM14 (Table 1).
Urogenital N. meningitidis classified as N. meningitidis by MLST, 16S rRNA gene
classification, and average nucleotide identity. We performed Illumina whole-ge-
nome sequencing (WGS) on all Saint Louis, MO (STL)-collected isolates. After draft ge-
nome assembly, scaffolds were submitted to the Neisseria MLST website (https://
pubmlst.org/neisseria/) to determine MLST and clonal complex (26). For 18 of 19
Neisseria isolates, MLST species classification agreed with MALDI-TOF MS classification.
One respiratory isolate (NM12), which MALDI-TOF MS was unable to classify to a single
species, was characterized as N. polysaccharea. MLST clonal complex indicated that 7
of 10 STL-collected urogenital N. meningitidis isolates fell into the sequence type 11
(ST-11) clonal complex (Table 1).
To determine the phylogenetic context of isolates, we downloaded the following
series of N. meningitidis genomes from NCBI and PubMLST: 28 N. meningitidis isolates
from urinary tract infections (UTIs) in the United States (13, 14), 3 N. meningitidis ST-11
isolates from cases of meningitis in MSM in the United States (39), 29 N. meningitidis
ST-11 isolates from a meningitis epidemic in Africa (40), and 8 N. meningitidis isolates
from non-ST-11 meningitis cases (Table S1).
Ribosomal RNA (rRNA) classification is used in the Aptima Combo 2 assay, with the
specific loci being proprietary (41), and in 16S rRNA gene sequence classification to
determine the bacterial operational taxonomic unit (OTU) or amplicon sequence vari-
ant (ASV) (28). Thus, we classified and compared 16S rRNA gene sequences across
Neisseria isolates. For all STL-collected isolates, 16S rRNA gene sequences were submit-
ted to the EZ BIoCloud taxonomic database for classification (28). 16S rRNA gene classi-
fication correlated with MLST for all isolates (Table 1). An approximate maximum likeli-
hood tree with NM12 as the outgroup shows N. gonorrhoeae sequences form a
monophyletic clade distinct from N. meningitidis sequences with N. meningitidis that
tested positive for N. gonorrhoeae using the A-CT/NG falling within the N. meningitidis
sequences (Fig. S1).
Finally, we used ANI for genomic species classification. Species were determined if
the genome in question had .95% pairwise ANI with the type genome (Fig. 1). All N.
meningitidis or N. gonorrhoeae isolates from urogenital samples that were identified by
MALDI-TOF MS and MLST were also identified as N. meningitidis or N. gonorrhoeae,
respectively, by ANI. NM12 did not fall above the cutoff for N. meningitidis, N. gonor-
rhoeae, or N. polysaccharea type strains. Pairwise ANI of all N. meningitidis isolates and
select reference N. meningitidis genomes indicated that ST-11 isolates form a distinct
cluster with ANI above 99% (Fig. 1). This cluster included all urogenital N. meningitidis
isolates for which N. gonorrhoeae was detected by A-CT/NG and one N. meningitidis re-
spiratory isolate, NM13. Thus, MALDI-TOF MS, MLST, 16S rRNA, and ANI agree on classi-
fication for 18 of 19 Neisseria isolates.
N. meningitidis urogenital isolates form a primary lineage that is distinct from
ST-11 meningitis isolates. To determine genomic similarity across N. meningitidis
genomes, we used a core genome alignment of 1,057 genes at 95% identity of all N.
meningitidis isolates, using NM12 as an outgroup. The phylogenetic tree of this align-
ment shows that urogenital N. meningitidis isolates primarily fall within a single lineage
(Fig. 2). All (3 of 3) STL-collected N. meningitidis isolates for which the A-CT/NG test
detected N. gonorrhoeae formed a single clade within STL-collected ST-11 urogenital N.
meningitidis isolates, suggesting a recent common ancestor. Of the STL-collected uro-
genital N. meningitidis isolates, 8/10 cluster together and form a sister clade to other
urogenital N. meningitidis isolates. This similarity suggests a single common ancestor
for 93% (31 of 33) of urogenital N. meningitidis isolates. Two urogenital STL-collected N.
meningitidis isolates, NM09 and NM15, did not cluster with other urogenital isolates,
and NM09 was, instead, highly related to a respiratory N. meningitidis isolate. Both
NM09 and NM15 isolates were nongroupable using serotyping methods, did not fall
into the ST-11 clonal complex, and were misclassified by RapID NH-; NM15 had been
misclassified as N. gonorrhoeae and NM09 was misclassified as Moraxella osloensis
Neisseria meningitidis from Urine Journal of Clinical Microbiology
February 2021 Volume 59 Issue 2 e01699-20 jcm.asm.org 5
 on F











(Table 1). ST-11 urethritis isolates were a sister clade to a lineage that included one
STL-collected respiratory isolate and all 3 of the MSM meningitis isolates. This clade
was a sister clade to the African ST-11 meningitis isolates. In contrast to N. meningitidis
urinary isolates, N. meningitidis respiratory isolates were highly diverse and distantly
related.
N. meningitidis urinary isolates are highly related to other urogenital isolates
and not respiratory isolates. SNP distances across whole genomes have been found
to provide higher resolution of phylogenetic distances than core genome comparisons
(37). Thus, to further investigate the genomic similarity of STL-collected N. meningitidis
isolates, we calculated pairwise SNP distances by mapping quality-filtered reads from
N. meningitidis isolates to the N. meningitidis type strain. To find groupings, we used a
grouping technique, “clique” (37), on STL-collected N. meningitidis isolates. We com-
pared pairwise SNP distances between N. meningitidis isolate pairs and iterated
FIG 1 Identification of clinical N. meningitidis (Nm) and N. gonorrhoeae (Ng) by ANI analysis. All N. meningitidis and N. gonorrhoeae isolates from urogenital
samples in St. Louis (STL) were characterized by pairwise ANI with all other isolates from STL and a subset of meningitis and ST-11 meningitis genomes.
Isolates cluster within 96% ANI for all but one N. gonorrhoeae and N. meningitidis isolate. A single isolate (NM12) from a respiratory sample did not fall
above a 96% cutoff for either N. meningitidis or N. gonorrhoeae type strain. Color strips indicate source of isolate, clonal complex identified my PubMLST,
and Aptima test results.
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FIG 2 Urogenital N. meningitidis isolates primarily fall within a single, highly related clade. An approximate maximum
likelihood tree of core genome alignment of St. Louis and select Neisseria isolates with tree branch lengths of .0.0001 is
shown. Two urogenital isolates collected from St. Louis fall outside of this clade and are distantly related to the ST-11 clonal
complex. All isolates that tested positive for N. gonorrhoeae fall into a clade with other urogenital N. meningitidis isolates. The
source is indicated by color of the tip, and Aptima test results are indicated by the shape of tip. Ng, N. gonorrhoeae.
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through each unique SNP distance cutoff to filter the isolate pairwise network list (Fig.
3A). For each cutoff, we found reciprocal groups and recorded the number of groups
and isolates per group. Then, groups were defined as complete subgraphs, where each
node in the group was connected to every other node in the group. The number of N.
meningitidis groups rose initially from 1 to 3 groups as SNP distances increased from
357 to 6,269. Only a single SNP distance of 5,624 SNPs had 4 groups, and immediately
after this peak, groups decreased again to 3, with a decline in group size to 1 after
FIG 3 Urogenital N. meningitidis isolates primarily form a single SNP pairwise distance-based
grouping. (A) Histogram of pairwise SNP distances indicates three modes of pairwise distances. The
first corresponds to within clade, the second to within species, and the third to between species. We
define variant threshold as variant pairwise distances that fall before 2,000 (black line). (B) Groupings
are visualized on the N. meningitidis core genome phylogeny. Group 1 includes 8 of 10 urogenital
isolates. Group 2 includes a respiratory and a urogenital isolate. The source is indicated by color of
the tip, and Aptima test results are indicated by the shape of the tip. Ng, N. gonorrhoeae.
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20,000 SNPs. Figure 3A shows the groups, which correspond to a SNP cutoff that
includes only highly related N. meningitidis isolates with less than 2,000 SNP distances.
Urogenital N. meningitidis isolates primarily formed a single grouping (Fig. 3B). The
first grouping includes 8/10 urogenital isolates and all ST-11 urethritis isolates. This
grouping fell entirely with the ST-11 urogenital clade described in the core genome
phylogeny (Fig. 2). A second grouping included a respiratory (NM11) and a urogenital
(NM09) isolate. These groupings suggest that while ST-11 urethritis isolates are highly
related with between 9.5 and 9.6 1024 pairwise SNPs/genome length, not all urogen-
ital isolates fall into the grouping, and one isolate shares high similarity (4.8 1024
pairwise SNPs/genome length) with a respiratory isolate.
N. meningitidis isolates have an antibiotic susceptibility profile distinct from N.
gonorrhoeae isolates. To consider clinical implications of misidentified N. meningitidis
isolates, we performed phenotypic AST on all STL-collected isolates. AST was per-
formed against azithromycin, penicillin, ceftriaxone, rifampin, ciprofloxacin, mino-
cycline, trimethoprim-sulfamethoxazole, and colistin. AST profiles varied between
N. gonorrhoeae isolates and urogenital N. meningitidis isolates (Fig. 4A). Most N.
meningitidis isolates tested nonsusceptible to azithromycin with MIC50/90 of 4mg/ml
(range, 0.5 to 4mg/ml) compared to N. gonorrhoeae isolates, which were mostly sus-
ceptible to azithromycin with MIC50 of 0.125mg/ml and MIC90 of 2mg/ml (range,
0.064 to 2mg/ml). The respiratory isolate, NM012, has a unique AST profile distinct
from both N. gonorrhoeae and N. meningitidis isolates in that it tested resistant to
azithromycin, penicillin, ciprofloxacin, and trimethoprim-sulfamethoxazole. We also
evaluated chromosomal point mutations that may account for antibiotic resistance
in Neisseria both by using PointFinder and by individually validating mutations of
known interest in specific genes (Table S2, Fig. S3). Point mutations for resistance
were primarily shared by species (Fig. S2). One prominent point mutation in N. men-
ingitidis isolates was in nonmosaic penA allele p.N512Y. This point mutation is asso-
ciated with mosaic penA, which can contribute to decreased susceptibility to
expanded-spectrum cephalosporins (42); however, all isolates in this study were
ceftriaxone susceptible with MIC of #0.016mg/ml. While all urogenital N. meningiti-
dis isolates and 1/3 respiratory N. meningitidis isolates had this mutation, this muta-
tion was not present in any N. gonorrhoeae isolate. Isolates within the same SNP
pairwise distance-based grouping had identical resistance mutation profiles (Fig. S2
and S3, Table S2).
FIG 4 The antibiotic susceptibility profile varies between N. gonorrhoeae isolates and urogenital N. meningitidis isolates. (A) The heatmap of AST profiles for
each isolate shows N. meningitidis and N. gonorrhoeae isolates organized by 16S phylogenetic gene tree, with major differences being that N. meningitidis
isolates are resistant to azithromycin and intermediate to penicillin, while N. gonorrhoeae isolates are largely susceptible to both antibiotics. Isolate NM12 has
a distinct antibiotic susceptibility profile that varies from both N. gonorrhoeae and N. meningitidis isolates. Color strips indicate the source of isolate, species
identification by ANI, and SNP pairwise distance-based grouping. (B) Distributions of MIC and zone diameter for N. meningitidis urogenital isolates and N.
gonorrhoeae respiratory isolates for azithromycin, rifampin, ciprofloxacin, and trimethoprim-sulfamethoxazole. Ng, N. gonorrhoeae; Nm, N. meningitidis.
Neisseria meningitidis from Urine Journal of Clinical Microbiology
February 2021 Volume 59 Issue 2 e01699-20 jcm.asm.org 9
 on F












As N. meningitidis becomes an increasingly recognized pathogen in the urogenital
system, accurate species identification of N. meningitidis and N. gonorrhoeae urogenital
isolates may be important for clinical care. Thus, it is essential to assess tools used for
identification and compare N. meningitidis and N. gonorrhoeae urogenital isolates. In
this study, we demonstrate that 30% (3/10) of urogenital N. meningitidis isolates were
misidentified as N. gonorrhoeae with the A-CT/NG NAAT and that these urogenital N.
meningitidis isolates were predominantly nonsusceptible to azithromycin. We found
that specific identification using MALDI-TOF MS, MLST, 16S rRNA gene sequence, and
ANI methods was 100% accurate for both urogenital N. meningitidis and N. gonor-
rhoeae isolates. However, our data indicate that some urogenital isolates of N. meningi-
tidis can cause false-positive detections with N. gonorrhoeae-specific molecular tests
and that some commensal Neisseria strains can be identified as N. meningitidis by
MALDI-TOF MS.
While NAAT tests such as the Aptima CT/NG Combo 2 or the Xpert CT/NG are the
standard of care for detection of N. gonorrhoeae from urine and genital specimens in
clinical laboratories, there is evidence that other Neisseria species can cause false-posi-
tive N. gonorrhoeae detections (7, 8). A previous report suggested these false-positive
results were sporadic and low level, as no isolate tested positive twice in their study
(8). In contrast, our findings were not sporadic, as 3 unique urogenital N. meningitidis
isolates were detected as N. gonorrhoeae both when tested as pure isolate suspensions
in saline and when spiked into urine. The Xpert CT/NG NAAT has two N. gonorrhoeae-
specific targets, both of which must be detected to return an N. gonorrhoeae-positive
result, while the Aptima CT/NG Combo 2 NAAT targets a region of the 16S rRNA to
detect N. gonorrhoeae. Since the exact locus of both the Aptima CT/NG Combo 2 and
the Xpert CT/NG tests are proprietary, we are unable to directly test for sequence dif-
ferences that may result in misidentifications. However, genomic characterization of
these isolates demonstrated that N. meningitidis isolates that test falsely positive for N.
gonorrhoeae form a distinct clade based on a core genome phylogeny, suggesting a
common ancestor and indicating a genomic component rather than random chance
or a sporadic error in the NAAT test is responsible for the false-positive N. gonorrhoeae
result.
Accurate identification of Neisseria isolates is important, as AST profiles vary
between N. gonorrhoeae and N. meningitidis isolates. Though rising rates of reduced
susceptibly to azithromycin in N. gonorrhoeae have been reported across the United
States (43), we found that the N. gonorrhoeae isolates tested in our study were primar-
ily susceptible to azithromycin (n=4/5), while urogenital N. meningitidis isolates col-
lected over the same time period as N. gonorrhoeae isolates were more likely to be
azithromycin nonsusceptible (n = 7/10). Our observation of largely azithromycin-sus-
ceptible N. gonorrhoeae is consistent with a previous study of a larger cohort of N. gon-
orrhoeae isolates recovered from the same institution that reported that azithromycin
nonsusceptibility was rare (,2%) (44). Interestingly, all N. meningitidis isolates that
tested falsely positive for N. gonorrhoeae were azithromycin nonsusceptible (n = 3/3).
Currently, a single dose of intramuscular ceftriaxone (250mg) plus a single dose of oral
azithromycin (1 g) is the primary treatment recommendation for uncomplicated gono-
coccal infection (45). Although dual therapy was primarily aimed at treatment of
uncomplicated chlamydial coinfections, routine combination therapy may hinder de-
velopment of antimicrobial resistance in N. gonorrhoeae, particularly in light of
increased cephalosporin resistance in the United States (43). Given the rare reports of
ceftriaxone-resistant N. meningitidis (46–48), ceftriaxone plus azithromycin dual ther-
apy is likely effective for treatment of urogenital N. meningitidis infection. However,
if azithromycin nonsusceptibility is common among urogenital N. meningitidis isolates
and in the setting of reduced susceptibility to 3rd-generation cephalosporins, current
gonococcal treatment guidelines may be suboptimal for urogenital N. meningitidis
infection. Interestingly, despite recent reports of ciprofloxacin-resistant, beta-lactamase-
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producing N. meningitidis serogroup Y (49), all of the N. meningitidis isolates evaluated in
this study were ciprofloxacin and ceftriaxone susceptible (n=13/13), though most were
nonsusceptible to penicillin (n = 10/13); beta-lactamase testing was not performed.
One hypothesis for conflicting identification of N. meningitidis isolates may be
increased HGT between N. gonorrhoeae and N. meningitidis. However, our 16S rRNA
gene sequence, MLST, and whole-genome analyses indicate that urogenital N. meningi-
tidis isolates are not more similar to N. gonorrhoeae than other N. meningitidis isolates.
The majority of urogenital isolates for which we performed genomic analyses (n = 35/
37) share a recent common ancestor. This suggests that most cases of N. meningitidis
urethritis are due to the spread of urethritis-associated N. meningitidis ST-11 and not
due to translocation and subsequent infection of respiratory or meningitis-associated
N. meningitidis isolates to the genitourinary tract, consistent with previous reports (11,
15). However, we did observe two instances where urogenital N. meningitidis isolates
were not from the ST-11 urethritis clade, and in one case, a respiratory N. meningitidis
isolate was highly related to a urinary N. meningitidis isolate. This suggests urogenital
N. meningitidis isolates do not derive exclusively from the ST-11 urethritis clade and
that transmission between body sites may be possible.
Studies have indicated that invasive N. meningitidis isolates from MSM are associ-
ated with colonization of the urethra or rectum (2) and that N. meningitidis urethritis
outbreaks are closely related to cases of invasive N. meningitidis in MSM populations,
suggesting that urethral colonization may contribute to invasive disease (11). In our
study, the sister clade to all ST-11 urethritis isolates included one respiratory isolate
and three meningitis-associated isolates from MSM patients. This phylogeny suggests
a common ancestor between MSM meningitidis and the origin of urogenital N. menin-
gitidis isolates. However, as this study is focused on urogenital N. meningitidis isolates,
only a subset of 54 N. meningitidis meningitis isolates was used for comparison, with a
focus on N. meningitidis isolates within ST-11. A more exhaustive study of N. meningiti-
dis meningitis isolates may find additional clades related to the urogenital NM isolates.
Further, in this data set, we do not see evidence for closely related urethritis and inva-
sive N. meningitidis isolates. It is possible that increasing the collection and analysis of
invasive and urogenital N. meningitidis isolates from meningitis patients may expand
further on this issue.
Public health-related activities associated with gonococcal infection, such as con-
tact-tracing and expedited partner therapy, may be indicated and initiated following
notification of this reportable infection. However, misidentification of N. meningitidis
can confound these activities, particularly if identification of N. gonorrhoeae and/or N.
meningitidis is inconsistent across currently available diagnostic tests. Increased vigi-
lance surrounding these (mis)identifications will be required for a more complete
understanding of the scope, epidemiology, susceptibility, and clinical outcomes asso-
ciated with N. meningitidis urogenital infections, as has been previously suggested
(50).
Overall, our findings demonstrate that some urogenital N. meningitidis isolates are
incorrectly identified as N. gonorrhoeae by the Aptima CT/NG NAAT despite being cor-
rectly identified as N. meningitidis by other molecular methods, including MALDI-TOF
MS, MLST, 16S rRNA gene sequencing, and ANI analysis. Further, these urogenital N.
meningitidis isolates are related to the ST-11 urethritis-associated N. meningitidis iso-
lates from across the United States. These isolates may be recovered from routine urine
cultures with increasing frequency, as laboratories transition to automated inoculation
and incubation systems. Finally, our studies have found that accurate identification of
N. meningitidis and N. gonorrhoeae may be important due to implications for public-
health related activities and potential differences in susceptibility profiles. Future stud-
ies further describing the scope, epidemiology, clinical course, and outcomes of N.
meningitidis-mediated urogenital infection compared to gonococcal infection will be
needed to justify strategies to identify and/or differentiate N. meningitidis from N. gon-
orrhoeae urogenital specimens.
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